Diego Alvarado

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis Patients

Epidermal Growth Factor Receptor

Disease Activity

Diffusion Weighted

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz, Lea Kiefer, Kunal Merchant, Diego Alvarado, Lawrence J Thomas, Thomas Hawthorne, Elizabeth Crowley, Margo Heath-Chiozzi, Martin Metz, Marcus Maurer
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy (2022)
Renata Sano, Kateryna Krytska, Colleen E Larmour, Pichai Raman, Daniel Martinez, Gwenda F Ligon, Jay S Lillquist, Ulisse Cucchi, Paolo Orsini, Simona Rizzi, Bruce R Pawel, Diego Alvarado, Yael P Mossé
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma. Science translational medicine 11 (483) (2020)
Diego Alvarado, Gwenda F Ligon, Jay S Lillquist, Scott B Seibel, Gerald Wallweber, Veronique M Neumeister, David L Rimm, Gerald McMahon, Theresa M LaVallee
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC. PloS one 12 (7) (2017)